Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement

Robert W. Schrier, Sally Burrows-Hudson, Louis Diamond, A. Peter Lundin, Maureen Michael, Donald L. Patrick, Thomas G. Peters, Neil R. Powe, James S. Roberts, John H. Sadler, Albert L. Siu, Kathleen N. Lohr, Richard A. Rettig

Research output: Contribution to journalArticlepeer-review

Abstract

The Institute of Medicine (IOM) committee that organized the conference reported in this issue of the journal on assessing quality of care and quality of life, wishes to emphasize that it regards the task of measuring quality as one that can be approached systematically, albeit with caution. Outcomes of end-stage renal disease (ESRD) care by dialysis and transplantation (and variations of outcomes among treatment units) and related processes of care need to be measured in ways useful to clinicians. In addition to clinical measures of outcome, the committee also favored giving greater attention to functional outcomes and health-related quality of life. The interest in maintaining and improving quality in the treatment setting reflects an underlying need to encourage its systematic assessment on a sustained basis, with appropriate weight devoted to practical issues.

Original languageEnglish (US)
Pages (from-to)383-388
Number of pages6
JournalAmerican Journal of Kidney Diseases
Volume24
Issue number2
DOIs
StatePublished - Jan 1 1994

Keywords

  • End-stage renal disease treatment
  • quality of care
  • quality of life

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement'. Together they form a unique fingerprint.

Cite this